Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Calvert, Amanda E."" wg kryterium: Autor


Wyświetlanie 1-70 z 70
Tytuł :
Development of a small animal peripheral challenge model of Japanese encephalitis virus using interferon deficient AG129 mice and the SA14-14-2 vaccine virus strain
Autorzy :
Calvert, Amanda E.
Pokaż więcej
Źródło :
In Vaccine 3 January 2014 32(2):258-264
Czasopismo naukowe
Tytuł :
Mutation of the dengue virus type 2 envelope protein heparan sulfate binding sites or the domain III lateral ridge blocks replication in Vero cells prior to membrane fusion
Autorzy :
Roehrig, John T.
Pokaż więcej
Źródło :
In Virology 5 July 2013 441(2):114-125
Czasopismo naukowe
Tytuł :
Domain-III FG loop of the dengue virus type 2 envelope protein is important for infection of mammalian cells and Aedes aegypti mosquitoes
Autorzy :
Erb, Steven M.
Pokaż więcej
Źródło :
In Virology 2010 406(2):328-335
Czasopismo naukowe
Tytuł :
Ability To Serologically Confirm Recent Zika Virus Infection in Areas with Varying Past Incidence of Dengue Virus Infection in the United States and U.S. Territories in 2016.
Autorzy :
Lindsey NP; Division of Vector-Borne Diseases, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Fort Collins, Colorado, USA .
Staples JE; Division of Vector-Borne Diseases, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Fort Collins, Colorado, USA.
Powell K; Division of Tuberculosis Elimination, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Rabe IB; Division of Vector-Borne Diseases, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Fort Collins, Colorado, USA.
Fischer M; Division of Vector-Borne Diseases, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Fort Collins, Colorado, USA.
Powers AM; Division of Vector-Borne Diseases, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Fort Collins, Colorado, USA.
Kosoy OI; Division of Vector-Borne Diseases, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Fort Collins, Colorado, USA.
Mossel EC; Division of Vector-Borne Diseases, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Fort Collins, Colorado, USA.
Munoz-Jordan JL; Division of Vector-Borne Diseases, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, San Juan, Puerto Rico.
Beltran M; Division of Vector-Borne Diseases, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, San Juan, Puerto Rico.
Hancock WT; Division of State and Local Readiness, Office of Public Health Preparedness and Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Toews KE; Division of State and Local Readiness, Office of Public Health Preparedness and Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Ellis EM; U.S. Virgin Islands Department of Health, Christiansted, U.S. Virgin Islands, USA.
Ellis BR; U.S. Virgin Islands Department of Health, Christiansted, U.S. Virgin Islands, USA.
Panella AJ; Division of Vector-Borne Diseases, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Fort Collins, Colorado, USA.
Basile AJ; Division of Vector-Borne Diseases, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Fort Collins, Colorado, USA.
Calvert AE; Division of Vector-Borne Diseases, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Fort Collins, Colorado, USA.
Laven J; Division of Vector-Borne Diseases, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Fort Collins, Colorado, USA.
Goodman CH; Division of Vector-Borne Diseases, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Fort Collins, Colorado, USA.
Gould CV; Division of Vector-Borne Diseases, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Fort Collins, Colorado, USA.
Martin SW; Division of Vector-Borne Diseases, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Fort Collins, Colorado, USA.
Thomas JD; Division of Preparedness and Emerging Infections, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Villanueva J; Division of Preparedness and Emerging Infections, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Mataia ML; American Samoa Department of Health, Fagaalu, American Samoa.
Sciulli R; State Laboratories Division, Hawaii Department of Health, Pearl City, Hawaii, USA.
Gose R; State Laboratories Division, Hawaii Department of Health, Pearl City, Hawaii, USA.
Whelen AC; State Laboratories Division, Hawaii Department of Health, Pearl City, Hawaii, USA.
Hills SL; Division of Vector-Borne Diseases, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Fort Collins, Colorado, USA.
Pokaż więcej
Źródło :
Journal of clinical microbiology [J Clin Microbiol] 2017 Dec 26; Vol. 56 (1). Date of Electronic Publication: 2017 Dec 26 (Print Publication: 2018).
Typ publikacji :
Journal Article; Validation Study
MeSH Terms :
Antibodies, Viral/*blood
Dengue/*epidemiology
Dengue Virus/*immunology
Immunoglobulin M/*blood
Zika Virus/*immunology
Zika Virus Infection/*diagnosis
American Samoa/epidemiology ; Cross Reactions ; False Positive Reactions ; Female ; Flavivirus/immunology ; Humans ; Incidence ; Male ; Neutralization Tests ; Puerto Rico/epidemiology ; United States/epidemiology ; United States Virgin Islands/epidemiology ; Zika Virus Infection/epidemiology ; Zika Virus Infection/virology
Czasopismo naukowe
Tytuł :
Non-structural proteins of dengue 2 virus offer limited protection to interferon-deficient mice after dengue 2 virus challenge.
Autorzy :
Calvert AE; Division of Vector-Borne Infectious Diseases, Centers for Disease Control and Prevention (CDC), Public Health Service, US Department of Health and Human Services, PO Box 2087, Fort Collins, CO 80522, USA.
Huang CY; Division of Vector-Borne Infectious Diseases, Centers for Disease Control and Prevention (CDC), Public Health Service, US Department of Health and Human Services, PO Box 2087, Fort Collins, CO 80522, USA.
Kinney RM; Division of Vector-Borne Infectious Diseases, Centers for Disease Control and Prevention (CDC), Public Health Service, US Department of Health and Human Services, PO Box 2087, Fort Collins, CO 80522, USA.
Roehrig JT; Division of Vector-Borne Infectious Diseases, Centers for Disease Control and Prevention (CDC), Public Health Service, US Department of Health and Human Services, PO Box 2087, Fort Collins, CO 80522, USA.
Pokaż więcej
Źródło :
The Journal of general virology [J Gen Virol] 2006 Feb; Vol. 87 (Pt 2), pp. 339-346.
Typ publikacji :
Journal Article
MeSH Terms :
Dengue/*prevention & control
Dengue Virus/*chemistry
Interferons/*deficiency
Vaccines, Synthetic/*immunology
Viral Nonstructural Proteins/*administration & dosage
Viral Vaccines/*administration & dosage
Animals ; Chimera ; Chlorocebus aethiops ; Genome, Viral ; Interferons/metabolism ; Mice ; Vero Cells ; Viral Nonstructural Proteins/genetics ; Viral Vaccines/immunology
Czasopismo naukowe
    Wyświetlanie 1-70 z 70

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies